Skip to content

Prolonged-release opioid for recovery

Agent for recovery: the opportunity for enhancing social inclusion afforded by prolonged-release buprenorphine formulations

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN27693404
Enrollment
70
Registered
2022-04-28
Start date
2022-04-19
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient participants prescribed a buprenorphine formulation by NHS Tayside Drug and Alcohol Recovery Services for their opioid dependence Mental and Behavioural Disorders Mental and behavioural disorders due to use of opioids

Interventions

Up to 60 patient participants will be recruited from drug and alcohol recovery services in Tayside, Scotland. Patient participants will be recruited from patients receiving prolonged-release subcutane

Sponsors

NHS Tayside
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Adult (aged 18 years or over) males and females 2. History of problematic substance abuse 3. Treated in NHS Tayside with either Buvidal (prolonged-release buprenorphine) or sublingual/oral lyophilisate buprenorphine OR 4. A member of the multidisciplinary alcohol and drug recovery service team in NHS Tayside (staff participant only) AND 5. People of any ethnic origin who are able to speak English and are willing to talk about and reflect on their experiences with the phenomenon under study 6. Willing to have the semi-structured interviews audio recorded 7. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Individuals will not be enrolled on the study if they are participating in the clinical phase of another interventional study or have done so within the last 30 days 2. Individuals who are participating in the follow-up phase of another interventional trial/study, or who are enrolled in an observational study, will be co-enrolled where the CIs of each study agree that it is appropriate

Design outcomes

Primary

MeasureTime frame
The thematic narrative of semi-structured interviews describing the views, meanings and values of participants at baseline (visit 1), visit 2 and visit 3

Secondary

MeasureTime frame
Measured at baseline (visit 1), visit 2 and visit 3: 1. Wellbeing of the population described using the Short Warwick Edinburgh Mental Wellbeing Scale (SWEMWBS) 2. Social and financial characteristics of the population described using financial inclusion data from Scottish Core Survey Questions (captured on Case Report Form) 3. Shifts in social networks described using social Identity mapping 4. Social inclusion of the population described using the 5R’s of citizenship tool

Countries

Scotland, United Kingdom

Contacts

Public ContactSarah Donaldson
SDonaldson001@dundee.ac.uk+44 (0)7967323195

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 14, 2026